Hypoxia modulates lipopolysaccharide induced TNF-α expression in murine macrophages

Experimental Cell Research

Volumn 314, Issue 6, 2008, Pages 1327-1336

  Liu, FengQin ^a   Liu, Yan ^a   Lui, Vincent C H ^a   Lamb, Jonathan R ^b   Tam, Paul K H ^a   Chen, Yan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

HIF 1 ; Hypoxia; Lipopolysaccharide; Macrophages; p38 MAPK; SB203580; TNF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; HYPOXIA; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MURINAE; MUS;

EID: 40049104711     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.01.007     Document Type: Article

References (45)

1. R.M. Andrade M. Wessendarp J.A. Portillo J.Q. Yang F.J. Gomez J.E. Durbin G.A. Bishop C.S. Subauste TNF receptor-associated factor 6-dependent CD40 signaling primes macrophages to acquire antimicrobial activity in response to TNF-alpha J. Immunol. 175 2005 6014 6021
2. M. Zakharova H.K. Ziegler Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells J. Immunol. 175 2005 5024 5033
3. A. Haimovitz-Friedman C. Cordon-Cardo S. Bayoumy M. Garzotto M. McLoughlin R. Gallily C.K. Edwards III E.H. Schuchman Z. Fuks R. Kolesnick Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation J. Exp. Med. 186 1997 1831 1841
4. K.J. Tracey Y. Fong D.G. Hesse K.R. Manogue A.T. Lee G.C. Kuo S.F. Lowry A. Cerami Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 330 1987 662 664
5. S.K. Leeper-Woodford P.D. Carey K. Byrne J.K. Jenkins B.J. Fisher C. Blocher H.J. Sugerman A.A. Fowler III Tumor necrosis factor. Alpha and beta subtypes appear in circulation during onset of sepsis-induced lung injury Am. Rev. Respir. Dis. 143 1991 1076 1082
6. M.A. Freudenberg D. Keppler C. Galanos Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin Infect. Immun. 51 1986 891 895
7. S. Akira K. Takeda Toll-like receptor signalling Nat. Rev. 4 2004 499 511
8. J. Lee L. Mira-Arbibe R.J. Ulevitch TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide J. Leukoc. Biol. 68 2000 909 915
9. P.Y. Perera T.N. Mayadas O. Takeuchi S. Akira M. Zaks-Zilberman S.M. Goyert S.N. Vogel CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression J. Immunol. 166 2001 574 581
10. C.A. Hazzalin L.C. Mahadevan MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev., Mol. Cell Biol. 3 2002 30 40
11. L. Chang M. Karin Mammalian MAP kinase signalling cascades Nature 410 2001 37 40
12. M. Brook G. Sully A.R. Clark J. Saklatvala Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade FEBS Lett. 483 2000 57 61
13. D. Kontoyiannis M. Pasparakis T.T. Pizarro F. Cominelli G. Kollias Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies Immunity 10 1999 387 398
14. J.C. Lee J.T. Laydon P.C. McDonnell T.F. Gallagher S. Kumar D. Green D. McNulty M.J. Blumenthal J.R. Keys S.W. Land vatter J.E. Strickler M.M. McLaughlin I.R. Siemens S.M. Fisher G.P. Livi J.R. White J.L. Adams P.R. Young A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 1994 739 746
15. P.R. Young M.M. McLaughlin S. Kumar S. Kassis M.L. Doyle D. McNulty T.F. Gallagher S. Fisher P.C. McDonnell S.A. Carr M.J. Huddleston G. Seibel T.G. Porter G.P. Livi J.L. Adams J.C. Lee Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site J. Biol. Chem. 272 1997 12116 12121
16. B. Frantz T. Klatt M. Pang J. Parsons A. Rolando H. Williams M.J. Tocci S.J. O'Keefe E.A. O'Neill The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding Biochemistry 37 1998 13846 13853
17. D.C. Underwood R.R. Osborn C.J. Kotzer J.L. Adams J.C. Lee E.F. Webb D.C. Carpenter S. Bochnowicz H.C. Thomas D.W. Hay D.E. Griswold SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence J. Pharmacol. Exp. Ther. 293 2000 281 288
18. B. van den Blink N.P. Juffermans T. ten Hove M.J. Schultz S.J. van Deventer T. van der Poll M.P. Peppelenbosch p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo J. Immunol. 166 2001 582 587
19. A.M. Badger J.N. Bradbeer B. Votta J.C. Lee J.L. Adams D.E. Griswold Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function J. Pharmacol. Exp. Ther. 279 1996 1453 1461
20. S.A. Wadsworth D.E. Cavender S.A. Beers P. Lalan P.H. Schafer E.A. Malloy W. Wu B. Fahmy G.C. Olini J.E. Davis J.L. Pellegrino-Gensey M.P. Wachter J.J. Siekierka RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase J. Pharmacol. Exp. Ther. 291 1999 680 687
21. J.E. Parrillo Pathogenetic mechanisms of septic shock N. Engl. J. Med. 328 1993 1471 1477
22. R.S. Hotchkiss I.E. Karl The pathophysiology and treatment of sepsis N. Engl. J. Med. 348 2003 138 150
23. M.A. Matthay Severe sepsis—a new treatment with both anticoagulant and antiinflammatory properties N. Engl. J. Med. 344 2001 759 762
24. P.E. Marik J. Varon The hemodynamic derangements in sepsis: implications for treatment strategies Chest 114 1998 854 860
25. E. Hervouet P. Pecina J. Demont A. Vojtiskova H. Simonnet J. Houstek C. Godinot Inhibition of cytochrome c oxidase subunit 4 precursor processing by the hypoxia mimic cobalt chloride Biochem. Biophys. Res. Commun. 344 2006 1086 1093
26. Z. Ji G. Yang S. Shahzidi K. Tkacz-Stachowska Z. Suo J.M. Nesland Q. Peng Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy Cancer Lett. 244 2006 182 189
27. A. Nagahira K. Nagahira H. Murafuji K. Abe K. Magota M. Matsui S. Oikawa Identification of a novel inhibitor of LPS-induced TNF-alpha production with antiproliferative activity in monocyte/macrophages Biochem. Biophys. Res. Commun. 281 2001 1030 1036
28. E. Hitti T. Iakovleva M. Brook S. Deppenmeier A.D. Gruber D. Radzioch A.R. Clark P.J. Blackshear A. Kotlyarov M. Gaestel Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element Mol. Cell Biol. 26 2006 2399 2407
29. M.C. Bosco M. Puppo S. Pastorino Z. Mi G. Melillo S. Massazza A. Rapisarda L. Varesio Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages J. Immunol. 172 2004 1681 1690
30. J. Han J.D. Lee L. Bibbs R.J. Ulevitch A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells Science 265 1994 808 811
31. J.C. Lee, S. Kassis, S. Kumar, A. Badger, J.L. Adams, p38 mitogen-activated protein kinase inhibitors—mechanisms and therapeutic potentials, Pharmacol. Ther. 82, 389–397. 82 (1999) 389–397.
32. J.L. Dean M. Brook A.R. Clark J. Saklatvala p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes J. Biol. Chem. 274 1999 264 269
33. J.M. Kyriakis J. Avruch Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol. Rev. 81 2001 807 869
34. A. Kotlyarov A. Neininger C. Schubert R. Eckert C. Birchmeier H.D. Volk M. Gaestel MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis Nat. Cell Biol. 1 1999 94 97
35. M. Comalada J. Xaus A.F. Valledor C. Lopez-Lopez D.J. Pennington A. Celada PKC epsilon is involved in JNK activation that mediates LPS-induced TNF-alpha, which induces apoptosis in macrophages Am. J. Physiol., Cell Physiol. 285 2003 C1235 C1245
36. Y. Seko N. Takahashi K. Tobe T. Kadowaki Y. Yazaki Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes Biochem. Biophys. Res. Commun. 239 1997 840 844
37. B.M. Thobe M. Frink M.A. Choudhry M.G. Schwacha K.I. Bland I.H. Chaudry Src family kinases regulate p38 MAPK-mediated IL-6 production in Kupffer cells following hypoxia Am. J. Physiol., Cell Physiol. 291 2006 C476 C482
38. S. Kumar J. Boehm J.C. Lee p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases Nat. Rev. Drug Discov. 2 2003 717 726
39. A. Zampetaki S.A. Mitsialis J. Pfeilschifter S. Kourembanas Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/p44 and PI3 kinase pathways FASEB J. 18 2004 1090 1092
40. T. Cramer R.S. Johnson A novel role for the hypoxia inducible transcriptionfactor HIF-1α: critical regulation of inflammatory cell function Cell Cycle 2 2003 192 193
41. R. Schmidhammer E. Wassermann P. Germann H. Redl R. Ullrich Infusion of increasing doses of endotoxin induces progressive acute lung injury but prevents early pulmonary hypertension in pigs Shock 25 2006 389 394
42. G.L. Semenza HIF-1 and human disease: one highly involved factor Genes Dev. 14 2000 1983 1991
43. G.L. Wang B.H. Jiang E.A. Rue G.L. Semenza Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension Proc. Natl. Acad. Sci. U. S. A. 92 1995 5510 5514
44. C.C. Blouin E.L. Page G.M. Soucy D.E. Richard Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha Blood 103 2004 1124 1130
45. C. Peyssonnaux P. Cejudo-Martin A. Doedens A.S. Zinkernagel R.S. Johnson V. Nizet Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis J. Immunol. 178 2007 7516 7519